Cannabis for the Treatment of Cancer: The Anticancer Activity of Phytocannabinoids and Endocannabino

Eighth Edition, March 2024: This is the most comprehensive update yet! Many new scientific studies and human cases have been added, plus substantial updates throughout the entire book to increase clarity, including better specification of what types of cannabis medicines were used in each case. Overall, there are 68 scientific studies analyzed and 205 unique human cases summarized.

The evidence that cannabis can directly fight cancer is truly overwhelming. Phytocannabinoids like THC, CBD, and CBG from the cannabis plant have been shown in scientific studies to fight brain, breast, cervical, cholangiocarcinoma, colon, gastric, Kaposi's sarcoma, leukemia, liver, lung, lymphoma, multiple myeloma, osteosarcoma, prostate, pancreatic, rhabdomyosarcoma, skin, and other cancers. Phytocannabinoids directly kill cancer cells as well as reduce proliferation, invasion, metastasis, and angiogenesis. There is also emerging evidence they stimulate the immune system to better kill cancer cells.

Dozens of human cases where phytocannabinoids were associated with anticancer effects have been published in formal medical journals hosted on PubMed and ResearchGate. Doctors, dispensaries, corporations, caregivers, and cancer patients themselves have also reported efficacy. There is even a double-blind, placebo-controlled trial indicating cannabis combined with chemotherapy can extend the lives of glioblatoma patients. While cannabis is not perfect and does not work for everyone, there is no doubt it has helped many patients in their battles against cancer.